1 Min Read
March 9 (Reuters) - Endo International Plc
* FDA staff : "among those abusing opana er, reformulation caused marked shift in the route by which drug is abused, from nasal to injection" Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.